Dr. Vincent Grasso, IPsoft’s Director of Cognitive Healthcare Services and a practicing physician with more than 30 years in the field, recently spoke with Forbes about the opioid crisis and how technology can help solve this nationwide issue.

In the piece, Dr. Grasso is featured along with other industry experts discussing how patients and providers can leverage various types of technology in a coordinated effort to fight and treat opioid addiction. Dr. Grasso believes a combination of virtual conversational agents (such as Amelia), machine learning and deep learning technologies can help the clinical community and society overall.

“I see the period of time between 2019 and 2024 as the window of opportunity to combat the opioid epidemic via the tactical utilization of technological advances, including, but not limited to, conversational AI, machine learning, high-performance computing, cloud-based platforms, IoT [Internet of Things] integrations, EHRs [electronic health records], and others.” Dr. Grasso says. Read the Forbes piece in its entirety for more.

To hear even more about Dr. Grasso’s vision for AI, listen to this HS. Health-Tech podcast where he discusses healthcare technology innovation in greater detail. During the podcast, Dr. Grasso says that today “there’s a whole new [AI] layer in the [clinical] technology stack,” including RPA, cognitive AI and virtual agents such as Amelia, which can be applied across the healthcare ecosystem.

New call-to-action